Total Visits
| Views | |
|---|---|
| Glembatumumab ... | 31 |
Total Visits Per Month
| February 2022 | March 2022 | April 2022 | May 2022 | June 2022 | July 2022 | August 2022 | |
|---|---|---|---|---|---|---|---|
| Glembatumumab ... | 15 | 14 | 1 | 1 | 0 | 0 | 0 |
File Visits
| Views | |
|---|---|
| glembatumumab_vedotin_patients_metastatic_gpnmb_overexpressing_triple_negative_breast_cancer_metric_2021.pdf | 16 |
| glembatumumab_vedotin_patients_metastatic_gpnmb_overexpressing_triple_negative_breast_cancer_metric_2021_material_suplementari2.pdf | 6 |
| glembatumumab_vedotin_patients_metastatic_gpnmb_overexpressing_triple_negative_breast_cancer_metric_2021_material_suplementari1.pdf | 5 |
Top country views
| Views | |
|---|---|
| United States | 16 |
| Spain | 7 |
| Canada | 2 |
| Germany | 2 |
| Belgium | 1 |
| Finland | 1 |
| France | 1 |
| Sweden | 1 |
Top cities views
| Views | |
|---|---|
| Chicago | 6 |
| Ashburn | 4 |
| Barcelona | 3 |
| Girona | 2 |
| Beauharnois | 1 |
| Boydton | 1 |
| Brussels | 1 |
| Helsinki | 1 |
| Karlsruhe | 1 |
| Montreal | 1 |